Abstract
Restrictive cardiomyopathy is a condition characterized by normal left ventricular cavity size and systolic function but with increased myocardial stiffness.1 This makes the ventricle incompliant and fills predominantly in early diastole. When atrial systolic function is maintained, the ventricle may accommodate a small volume of blood during atrial systole but at the expense of raising the enddiastolic pressure. These physiologic disturbances are associated with raised left atrial pressures, atrial dilatation, and possible arrhythmias.2
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Siegel RJ, Shah PK, Fishbein MC. Idiopathic restrictive cardiomyopathy. Circulation 1984; 70: 165–169.
Benotti JR, Grossman W, Cohn PF. Clinical profile of restrictive cardiomyopathy. Circulation 1980; 61: 1206–1212.
Roberts WC, Liegler DG, Carbone PP. Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med 1969; 46: 28–42.
Candell-Riera J, Permanyer-Miralda G, Soler-Soler J. Echocardiographic findings in endomyocardial fibrosis. Chest 1982; 82: 88–90.
Child JS, Levisman JA, Abbasi AS, et al. Echocardiographic manifestations of infiltrative cardiomyopathy. A report of seven cases due to amyloid. Chest 1976; 70: 726–731.
Cueto-Garcia L, Tajik AJ, Kyle RA, et al. Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heart. Mayo Clin Proc 1984; 59: 589–597.
Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204–1211.
Short EM, Winkle RA, Billingham ME. Myocardial involvement in idiopathic hemochromatosis. Morphologic and clinical improvement following venesection. Am J Med 1981; 70: 1275–1279.
Henein MY, Gibson DG. Abnormal subendocardial function in restrictive left ventricular disease. Br Heart J 1994; 72: 237–242.
Hess OM, Turina M, Senning A, et al. Pre-and postoperative findings in patients with endomyocardial fibrosis. Br Heart J 1978; 40: 406–415.
George BO, Gaba FE, Talabi AI. M-mode echocardiographic features of endomyocardial fibrosis. Br Heart J 1982; 48: 222–228.
Vijayaraghavan G, Davies J, Sadanandan S, et al. Echo-cardiographic features of tropical endomyocardial disease in South India. Br Heart J 1983; 50: 450–459.
Acquatella H, Schiller NB, Puigbo JJ, et al. Value of two-dimensional echocardiography in endomyocardial disease with and without eosinophilia. A clinical and pathologic study. Circulation 1983; 67: 1219–1226.
Davies J, Gibson DG, Foale R, et al. Echocardiographic features of eosinophilic endomyocardial disease. Br Heart J 1982; 48: 434–440.
Gottdiener JS, Maron BJ, Schooley RT, et al. Two-dimensional echocardiographic assessment of the idiopathic hypereosinophilic syndrome. Anatomic basis of mitral regurgitation and peripheral embolization. Circulation 1983; 67: 572–578.
Olson LJ, Baldus WP, Tajik AJ. Echocardiographic features of idiopathic hemochromatosis. Am J Cardiol 1987; 60: 885–889.
Hwang B, Meng CC, Lin CY, et al. Clinical analysis of five infants with glycogen storage disease of the heart-Pompe’s disease. Jpn Heart J 1986; 27: 25–34.
Bass JL, Shrivastava S, Grabowski GA, et al. The M-mode echocardiogram in Fabry’s disease. Am Heart J 1980; 100 (6 Pt 1): 807–812.
Cueto-Garcia L, Reeder GS, Kyle RA, et al. Echo-cardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985; 6: 737–743.
Siqueira-Filho AG, Cunha CL, Tajik AJ, et al. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation 1981; 63: 188–196.
Klein AL, Hatle LK, Burstow DJ, et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. JAm Coll Cardiol 1989; 13: 1017–1026.
Henein MY, Amadi A, O’Sullivan C, et al. ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease. Heart 1996; 76: 326–331.
Child JS, Krivokapich J, Abbasi AS. Increased right ventricular wall thickness on echocardiography in amyloid infiltrative cardiomyopathy. Am J Cardiol 1979; 44: 1391–1395.
Klein AL, Hatle LK, Taliercio CP, et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 1991; 83: 808–816.
Chandrasekaran K, Aylward PE, Fleagle SR, et al. Feasibility of identifying amyloid and hypertrophic cardiomyopathy with the use of computerized quantitative texture analysis of clinical echocardiographic data J Am Coll Cardiol 1989; 13: 832–840.
Lewin RF, Mor R, Spitzer S, et al. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985; 110 (1 Pt 1): 116–122.
Candell-Riera J, Lu L, Seres L, et al. Cardiac hemochromatosis: beneficial effects of iron removal therapy. An echocardiographic study. Am J Cardiol 1983; 52: 824–829.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag London
About this chapter
Cite this chapter
Henein, M.Y., Sheppard, M., Pepper, J., Rigby, M. (2004). Restrictive Cardiomyopathy. In: Clinical Echocardiography. Springer, London. https://doi.org/10.1007/978-1-4471-3785-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3785-6_11
Publisher Name: Springer, London
Print ISBN: 978-1-84996-910-9
Online ISBN: 978-1-4471-3785-6
eBook Packages: Springer Book Archive